Biohoo Life Science Directory
|
|
3H Biomedical AB
3H Biomedical is one of the leading suppliers of high-value primary human cells and cell-based products for life science, cell research and drug discovery. The company’s rapidly growing product offerings are cost-effective, time saving tools to help scientists become more productive, more competitive and more innovative. 3H Biomedical markets its products directly or through distributors. The company is located in Uppsala Science Park, Sweden, just 35 km from Arlanda international airport. 3H Biomedical collaborates with ScienCell Research Laboratories in San Diego, U.S.A..We are now offering 130 types of primary human cells for research and drug discovery. |
Sweden
|
|
|
Bioceros B.V.
Bioceros is one of Europe’s premier providers of GMP-ready protein producing cell lines, based on our proprietary serum-free, suspension CHO platform (named CHOBC ™). Bioceros’ Cell Line Generation capabilities are underscored by its nomination by DSM and Crucell as the first pre-approved Europe-based PER.C6® cell line generation partner. All the Cell Line Generation work that we perform is Quality Controlled. |
The Netherlands
|
|
|
MARINPHARM GmbH
MARINPHARM GmbH generates and markets genetically modified stable cell lines that are fluorescent and are used for basic and applied research. MARINPHARM GmbH generates individually for clients stable cell lines expressing a protein defined by the client and their choice of fluorescent markers. MARINPHARM GmbH has been created in 2003 and is situated in the Biotechnology Park Luckenwalde in the state of Brandenburg. |
Germany
|
|
|
Medicyte GmbH
We are a private company focused on controlled and scalable production of human primary cells. Our vision is to establish our unique and proprietary technologies as gold standards and preferred source for human primary cells and human cell-based products for research, industrial and therapeutic applications. Medicyte was founded in June 2007. |
Germany
|
|
|
MYOSIX SA
Myosix dedicates its strong expertise in muscle cell technology to the development of cell-based therapies for diseases with unmet medical needs, such as myopathies. Myosix has developed an innovative technique for culturing adult skeletal muscle cells. This unique technique generates very large quantities of muscle precursor cells (myoblasts) from a small muscular biopsy sample. |
France
|
<<
Start <
Prev 1 2 Next >
End >>